Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A

Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A

Guoqing Gu,1,* Chenxi Hu,1,* Kaiyuan Hui,1 Huiqin Zhang,1 Ting Chen,1 Xin Zhang,2 Xiaodong Jiang1 1Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, 222000, People’s Republic of China; 2Lianyungang Clinical College of Nanj...

Full description

Bibliographic Details
Main Authors: Gu G, Hu C, Hui K, Zhang H, Chen T, Zhang X, Jiang X
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:International Journal of Nanomedicine
Subjects:
advanced non-small cell lung cancer
anlotinib resistance
exosome
microrna.
Online Access:https://www.dovepress.com/exosomal-mir-136-5p-derived-from-anlotinib-resistant-nsclc-cells-confe-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/exosomal-mir-136-5p-derived-from-anlotinib-resistant-nsclc-cells-confe-peer-reviewed-fulltext-article-IJN

Similar Items